⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for aromatase inhibitors (ais)

Every month we try and update this database with for aromatase inhibitors (ais) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Phase II Trial of SAHA & Tamoxifen for Patients With Breast CancerNCT00365599
Breast Cancer
suberoylanilide...
tamoxifen citra...
18 Years - H. Lee Moffitt Cancer Center and Research Institute
Evaluation of Biomarkers Associated With Response to Subsequent Therapies in Subjects With HER2-Positive Metastatic Breast CancerNCT02213042
Neoplasms, Brea...
Lapatinib
Trastuzumab
Aromatase Inhib...
18 Years - Novartis
Capecitabine Metronomic Chemotherapy Plus Aromatase Inhibitor for Postmenopausal Hormone Receptor Positive Breast CancerNCT01924078
Breast Cancer
Capecitabine
aromatase Inhib...
18 Years - Fudan University
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: